share_log

复星医药关于2022年非公开发行新增募投项目实施主体的公告

Announcement regarding the implementation subject of the newly raised investment projects in the non-public issuance of Fosun Pharma in 2022.

SZSI ·  Jul 31

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.